Clinical trial
AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation
NCT05035277 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- December 4, 2021
- Completion date
- June 5, 2026
- Enrollment
- 360 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
aortic stenosis